Provided by Tiger Trade Technology Pte. Ltd.

Akari Therapeutics PLC

9.10
+1.2315.63%
Post-market: 9.160.0600+0.66%16:25 EDT
Volume:254.06K
Turnover:2.27M
Market Cap:17.72M
PE:-0.57
High:9.96
Open:8.10
Low:7.95
Close:7.87
52wk High:49.60
52wk Low:3.02
Shares:1.95M
Float Shares:694.50K
Volume Ratio:11.09
T/O Rate:36.58%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-15.9015
EPS(LYR):-20.5537
ROE:-140.09%
ROA:-19.10%
PB:0.95
PE(LYR):-0.44

Loading ...

Aug 13, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 13, 2026

Major Issues Report

Form 8-K - Current report
Aug 12, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Aug 07, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Jul 02, 2026

Major Issues Report

Form 8-K - Current report
Jun 26, 2026

Major Issues Report

Form 8-K - Current report
Jun 26, 2026

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jun 08, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
May 22, 2026

Major Issues Report

Form 8-K - Current report
May 19, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2026

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Mar 30, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 17, 2026

Major Issues Report

Form 8-K - Current report
Mar 03, 2026

Major Issues Report

Form 8-K - Current report
Jan 28, 2026

Correspondence

Form CORRESP - Correspondence
Jan 23, 2026

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Dec 17, 2025

Major Issues Report

Form 8-K - Current report
Dec 17, 2025

Major Issues Report

Form 8-K - Current report
Dec 08, 2025

Major Issues Report

Form 8-K - Current report
Dec 02, 2025

Correspondence

Form CORRESP - Correspondence